Oxford Haemodynamic Adaptation to Reduce Pulsatility Trial
Condition: Small Vessel Cerebrovascular Disease Interventions: Drug: Sildenafil; Drug: Cilostazol; Drug: Placebo Sponsors: University of Oxford; Wellcome Trust Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2019 Category: Research Source Type: clinical trials